AstraZeneca PLC (AZN) Financials

AZN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 114.0 billion 66.6 billion
Dec. 31, 2025 114.1 billion 65.4 billion
Sept. 30, 2025 114.5 billion 68.5 billion
June 30, 2025 112.4 billion 67.6 billion

AZN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 1.8 billion ?
Dec. 31, 2025 1.4 billion ?
Sept. 30, 2025 4.4 billion ?
June 30, 2025 1.5 billion ?

AZN Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 3.9 billion
Dec. 31, 2025 2.4 billion
Sept. 30, 2025 2.5 billion
June 30, 2025 3.1 billion

AZN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 7.7 billion 24.5 billion 1.9 billion
Dec. 31, 2025 5.7 billion 24.7 billion 1.8 billion
Sept. 30, 2025 8.2 billion 24.7 billion 1.8 billion
June 30, 2025 7.1 billion 24.7 billion 1.6 billion

AZN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 1.6 billion
Dec. 31, 2025 1.6 billion
Sept. 30, 2025 1.6 billion
June 30, 2025 1.6 billion

AZN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 1.5 billion 3.5 billion 5.1 billion 141.0 million
Dec. 31, 2025 1.1 billion 3.9 billion 5.6 billion 153.0 million
Sept. 30, 2025 686.0 million 3.7 billion 5.2 billion 148.0 million
June 30, 2025 1.9 billion 3.5 billion 5.0 billion 143.0 million

AZN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 15.3 billion 2.7 billion
Dec. 31, 2025 15.5 billion 3.1 billion
Sept. 30, 2025 15.2 billion 2.8 billion
June 30, 2025 14.5 billion 2.5 billion

AZN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

AZN

Price: $169.34

52 week price:
137.22
212.71

Dividend Yield: 1.68%

5-year range yield:
1.28%
4.09%

Forward Dividend Yield: 2.54%

Payout Ratio: 48.78%

Payout Ratio Range:
-1096.88%
786.97%

Dividend Per Share: 4.30 USD

Earnings Per Share: 6.63 USD

P/E Ratio: 27.34

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: United Kingdom

Volume: 4.8 million

Ebitda: 1.8 billion

Market Capitalization: 294.9 billion

Average Dividend Frequency: 2

Years Paying Dividends: 34

DGR3: 2.65%

DGR5: 2.09%

DGR10: -4.71%

DGR20: 10.52%

Links: